Cell Lung Cancer: A Study of Long-Term Survival After Vinorelbine
Julien, S., et al.
v.5, no.2 The Oncologist (April 2000): 115-119
Reports the results of a study that showed a percentage of patients with
inoperable NSCLC can experience prolonged survival after treatment with
single agent Navelbine.
(Navelbine) - Recent MEDLINE Abstracts (PubMed)
- Clinical Trials (ClinicalTrials.gov)
Vinorelbine (Navelbine) & Cisplatin
II Trial of Docetaxel and Vinorelbine in Patients with Advanced
Non-Small Cell Lung Cancer (Journal of Clinical Oncology)
Abstract of a Journal of Clinical Oncology article (March
2000 issue) reporting the results of a study that found docetaxel and
vinorelbine, both given every 2 weeks, is a highly active combination
for the treatment of advanced NSCLC. [3/00]
and Cisplatin - Recent MEDLINE Abstracts (PubMed)